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ABSTRACT
Introduction: During the last three decades hematopoietic stem cell transplantation (HSCT) has become 
a well-established treatment for many hematologic malignancies. The most important limitation for 
HSC transplantation is the low number of hematopoietic stem cells (HSC) that can lead to delayed 
engraftment or graft failures. Numerous attempts have been made to improve in vitro HSC expansion 
via optimization of various methods such as isolation techniques, supplementing with growth factors, 
utilizing stromal cells as feeder layer and other culture conditions. Objective: This project is aimed to 
decipher the efficiency of an isolation technique and retrieval of culture expanded HSC from feeder 
layer using two different harvesting methods. Materials and Methods: Hematopoietic stem cells from 
human umbilical cord blood were isolated via MACS mediated CD34+ double sorting. Then, the cells 
were cultured onto MSC feeder layer for 3 and 5 days. Culture expanded cells were harvested using 
two different harvesting method namely cell aspiration and trypsinization methods. Hematopoietic stem 
cell expansion index were calculated based on harvesting methods for each time point. Results: The 
numbers of HSC isolated from human umbilical cord blood were 1.64 x 106 and 1.20 x106 cells at single 
and double sortings respectively. Although the number of sorted cells diminished at the second sorting 
yet the yield of CD34+ purity has increased from 43.73% at single sorting to 81.40% at double sorting. 
Employing the trypsinization method, the HSC harvested from feeder layer showed a significant increase 
in expansion index (EI) as compared to the cell aspiration harvesting method (p≤ 0.05). However, the 
purity of CD34+ HSC was found higher when the cells were harvested using aspiration method (82.43%) 
as compared to the trypsinization method (74.13%). Conclusion: A pure population of CD34+ HSC 
can be retrieved when the cells were double sorted using MACS and expanded in culture after being 
harvested using cell aspiration method.   
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INTRODUCTION
Haematopoietic stem cell (HSC) transplantation has become an inevitable therapy for many blood related disorders. 
Among all stem cell-based therapies, hematopoietic stem cell transplantation is the only one with a well-established 
clinical regimen and remains an effective approach for patients with certain haematological diseases.1 Basically, HSC 
transplantation involves the intravenous infusion of autologous or allogeneic stem cells collected from bone marrow, 
mobilized peripheral blood stem cells or umbilical cord blood to the patients.2 Although bone marrow serves as an ideal 
source for HSC yet several factors such as very painful invasive procedure, post infections risk, limitation of donor 
availability and the age of patients often circumvent its wide applications.3 However, the successful transplantation of 
umbilical cord blood (UCB) in 1988 has open the gateway to UCB for being considered as an attractive alternative 
source of HSC in the treatment of haematological malignancies (leukaemia & lymphoma) and non-malignant blood 
diseases (thalassaemia & sickle cell disease).4,5
Although UCB transplantation has become a big breakthrough in the field of cellular therapy, yet the number 
of HSC harvested for cryopreservation or therapy still remains an issue. A substantial number of umbilical cord blood 
that has been collected by the national and private cord blood banks are discarded due to low number of mononuclear
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cells which subsequently leads to smaller stem cells fraction. Insufficient numbers of transplantable/storable stem cells 
barricade the success of clinical and experimental HSC transplantation.6 Alternatively, numerous attempts have been 
made to expand HSC derived from UCB in ex vivo via various means such as supplementation with a range of growth 
factors and basal media; variety of extracellular matrixes; dynamic 3D culture system and utilizing stromal cells as 
feeder layer.6-8 
The initial number of CD34+ HSC cells for expansion is a crucial parameter that affects the outcome of the in 
vitro culture. Besides the optimal culture growth media with mitogenic cytokines, supply of relatively pure population 
of CD34+ cells for the initial culture escalates the number of expanded CD34+ cells. The physiological condition of 
HSC in bone marrow requires the stromal compartment as a niche to self-replicate and further differentiate into mature 
hematopoietic cells.9 Thus many HSC expansion at laboratory level consumes mesenchymal stem cells as feeder 
layer to mimic such in vivo condition as MSC in bone marrow niche provide HSC the necessary extracellular matrix 
and cytokines.10 However, due to the adhesive nature of HSC and MSC in co-culture system, researchers often face 
difficulties in separating HSC from feeder cell layer with either a substantial number of HSC retained at the adherent 
feeder cells or contamination of feeder cells due to forceful harvest.    
Thus, the present study is aimed to isolate a higher purity of HSC for the initial culture and identify a good 
harvesting method to collect MSC-feeder layer expanded HSC. This study indicates that a double magnetic activated 
sorting system (MACS) together with cell aspiration harvesting method yield high fraction of pure CD34+ HSC.    
MATERIALS AND METHOD
Samples
Fresh human umbilical cord blood (HCB) was collected from Britannia Hospital, Kajang after obtaining the written 
informed consent from parents. Approximately 50 to 70 ml of HCB was collected using a commercially available cord 
blood collecting set which contains 23 ml CPDA-1 (Citrate Phosphate Dextrose Adenine) as an anticoagulant (JMS 
SINGAPORE PTE LTD). Samples were transported on ice from Britannia Hospital to processing laboratory using 
a leak-proof container at 16-22 °C. Thirty (30) HCB samples were collected, each experiments were repeated with 
at least of 5 samples. The approval and ethical clearance from the Faculty of Medicine and Health Sciences (UPM) 
was attained upon commencement of the study [Reference No: UPM/FPSK/PADS/T7-MJKEtikaPer/F01{Lect_
Sept(08)14}].
Isolation and culture of HSC
Mononuclear cells were isolated immediately using density gradient centrifugation with Ficoll-Hypaque (Biochrom 
KG, Berlin, Germany). Briefly, HCB was diluted with 1x PBS prior to layer on Ficoll-Hypaque solution in 50ml 
centrifugation tube at ratio 1:1. Samples were subjected to the centrifugation of 2000 RPM for 30 min at room 
temperature without deceleration process. Mononuclear cells were harvested at the interface of plasma and Ficoll-
Hypaque and washed once with 1 x PBS.  Mononuclear cells were labelled with CD34 monoclonal antibody conjugated 
with magnetic microbeads. Labelled cells were passed through an affinity column using Auto-MACS system. The 
column enables a high gradient magnetic separation of CD34 positive selection (Miltenyi Biotec, Bergisch-Gladbach, 
Germany). Sorted CD34+ cells were subjected to second column sorting to further purify CD34+ HSC. CD34+ 
HSC were suspended in Iscove’s Modified Dulbecco’s Media (IMDM) (ThermoFisher Scientific, USA)  at a density 
of 2x104 cells/well, together with 1% PenStrep (ThermoFisher Scientific, USA), 0.5% Fungizone  (ThermoFisher 
Scientific, USA) and 10% foetal bovine serum (FBS) (ThermoFisher Scientific, USA). HSC suspensions were seeded 
on 24-well plates at a density of 2x104 cells/cm2 on top of a confluent Mitomycin C treated (Sigma) (0.5 mg/ml 
solution prepared in IMDM+10% FBS) MSC layer. Cells were incubated in a 37°C and 5% CO2 humidified incubator, 
for 3, and 5 days, without medium change.
Flow cytometer analysis
The purity of CD34+ HCS was assessed by flow cytometry using allophycocyanin (APC)-conjugated anti-human 
CD34 monoclonal antibody according to the manufacturers’ protocol. Briefly, 105 to 106 of HSC were stained with 
5 µl anti-human monoclonal antibodies (CD34-APC and CD45- PerCP-Cy5.5) for 20 minutes at 2-8ºC.  Then HSC 
were washed with 1x PBS and immediately analysed using FACSS Fortessa (BD Biosciences, San Jose, CA, USA) 
flow cytometer. A total of 10,000 events were recorded and data were analysed with BD FACSDiva Software V.6.1.1 
(BD Biosciences, San Jose, CA, USA). An additional staining with propidium iodide (PI) was performed to allow 
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exclusion of dead cells. Hematopoietic stem cells are identified based on CD34high CD45low population in dot plot. 
The positivity of any given antibody stain was determined by quadrant analysis as compared to the isotypic negative 
controls (cells stained with the isotype controls for, PerCP-Cy5.5 Mouse IgG1 and APC Mouse IgG1 were used as 
negative controls). 
Cell harvesting methods 
Upon co-culturing with MSC feeder layer, HSC were either harvested by a conventional cell aspiration method by 
pipetting and trypsinization methods to retrieve HSC.  For cell aspiration method, the supernatant of the co-culture 
were aspirated and the cells in the supernatant were collected via centrifugation process. Feeder layer were gently 
washed twice with PBS to remove any remaining semi-adherent HSC that loosely attached with feeder layer. For the 
second method (trypsinisation), the floating HSC were harvested from supernatant; collected via centrifugation  and 
the remaining semi-adherent HSC were harvested by swiftly incubated with 3ml of trypsin for 3-5 min in 37°C and 
5% CO2 humidified incubator.  After completion of harvesting, the remaining feeder layer was subjected to the phase 
contrast microscopical examination to determine the efficiency of harvesting methods. 
Expansion index 
Expansion index (EI) of HSC was performed using trypan blue exclusion cell count method.  In brief, HSC were 
plated into 24-well plate at 2×104 HSC/well; on mitomycin C treated MSC layer; grown without media change. Cells 
were harvested at day 3 and 5; counted on a hemacytometer using trypan blue exclusion cell count. To calculate the 
EI, the number of cells at the time point of interest were divided to the number of cells at day 0.
Statistical analysis
Descriptive analysis was performed for all variables. Comparisons for all pairs were performed by Student’s t-test. 
For all tests, statistical significance was defined by a p ≤ 0.05.   All data were analysed using SPSS VERSION 17. 
Values for measurements were presented as mean ± SD. 
 RESULTS
Double sorting process increases the quality but not the quantity of CD34+ HSC yield 
The number of viable CD34+ HSC after the single and double sorting was manually counted using hemocytometer 
under the phase contrast microscope. Viability of cells was determined by trypan blue exclusion test where the nucleus 
of dead cells stained with trypan blue. The mononuclear cells from cord blood were subjected for MACS CD34 
positive selection with initial cell numbers of 172×106/3ml. Upon single and double sorting, the number of CD34+ 
HSC collected were 1.64×106 and 1.20×106 respectively (Figure 1A). The second enrichment process had lowered the 
number of sorted cells to 70% of initially sorted cells (single sorting). After the single and double sorting process, the 
percentage of cells that expressing CD34 marker were 43.73% and 81.40% respectively (Figure 1B).
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Figure 1: Number and purity of CD34+ HSC after the single and double sorting. After MACS positive sorting 
process, number of CD34+ cells were counted using hemocytometer (A). Isolated cells were stained with CD34 
monoclonal antibody and analysed by flow cytometer (B). Purity of CD34+ HSC harvested at double sorting is higher 
compared to the single sorting (p≤0.05). Data are given as means ± SD (n = 5).
Trypsinization method harvests higher CD34+ HSC
Once purified HSC cultured on to MSC feeder layer, the proliferation of HSC was measured using expansion index 
on day 3 and day 5 by harvesting cells via cell aspiration and trypsinization methods. Cells which had been harvested 
using trypsinization process showed a statistically significant (p≤ 0.05) higher HSC expansion index (EI) as compared 
with the ordinary cell aspiration method that utilizes pipetting at both collecting points.   Table 1 and Figure 2 show 
the expansion index (EI) of HSC at day 3, and 5 by cell aspiration and trypsinization harvesting method. 
Table 1: Expansion index of HSC after cell aspiration and trypsinization harvesting
Figure 2: Expansion index of HSC after cell aspiration and trypsinization harvesting
Purified HSC at 2.0x104 cell number were cultured for 3 and 5 days. Thereafter, HSC were harvested using cell 
aspiration and trypsinization methods and the number of harvested HSC was reported as EI. Number of cells harvested 
from trypsinization method is higher compared to the cell aspiration method (p≤0.05). Data are given as means ± SD 
(n = 5).
Harvesting method Day Mean SD P values
Cell Aspiration 3 2.00 0.25
5 2.95 0.2
Trypsinization 3 2.35 0.33 0.002*
5 4.40 0.57 0*
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Cell aspiration harvesting method yields higher purity of CD34+ HSC 
In order to investigate the effect of both harvesting method on HSC purity, the percentage of CD34 was measured by 
flow cytometer analysis. Flow cytometer analysis showed a higher percentage of CD34+ HSC when cell aspiration 
harvesting method was utilized in comparison with trypsinization method. At least 10x103 cells harvested on gated 
region of HSC and further sub-fractioned to CD45-CD34+ cells. The percentage of CD34+ HSC from cell aspiration 
and trypsinization harvesting methods were 82.43% and 74.13% respectively (Fig. 3). However, the difference in HSC 
purity from both harvesting methods was not statistically significant (p>0.05). Figure 3 shows the purity of CD34+ 
HSC obtained after harvesting by cell aspiration and trypsinization methods.
Figure 3:  The purity of CD34+ HSC harvested from cell aspiration and trypsinization methods. The dot plot 
of flow cytometer analysis shows a representative data on purity of CD34+ HSC harvested using cell aspiration 
and trypsinization methods. At least 10x103 cells harvested on gated region of HSC and the density plot shows 
representative data of an individual sample (A). Purity of CD34+ HSC harvested from cell aspiration method is higher 
compared to the trypsinization (B). Data are given as means ± SD (n = 5).
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DISCUSSION
Due to its inevitable therapeutic value, hematopoietic stem cells (HSC) have become major stem cells that have been 
commonly used in many haematology related transplantations. Although the early establishment of HSC and initial 
clinical uses started with bone marrow, later other post-natal and peri-natal tissues such as peripheral blood and 
umbilical cord blood were identified as potential source for HSC. Among all, umbilical cord blood derived HSC serves 
as an ideal source for stem cells because of less ethical concern, abundantly available as post-delivery waste products 
and the primitive nature of HSC.    
Two common methods that have been widely consumed to isolate HSC are fluorescent-activated cell sorting 
(FACS) and magnetic-activated cell sorting (MACS) using a single or an array of specific antibodies.11,12 In the 
present study, CD34+ HSC were sorted using monoclonal anti-CD34 antibody conjugated with magnetic microbeads. 
Although, there are several surface markers being used as of single or in combination to sort HSC, yet the use of CD34 
has been the utmost preference in isolating and characterizing HSC. In comparison to FACS, MACS method is much 
feasible and affordable. Sorting technique using magnetic microbeads conjugated antibody allows an aseptic isolation 
of desired cell population as this could easily performed in cell culture biosafety cabinet. Despite the multiple markers 
mediated isolation and identification of target population by flow cytometer which sanctions much specific isolation, 
yet this method require a highly trained personnel and often not fully warrant the aseptic sorting. Since the frequency 
of HSC in human umbilical cord blood is very low as reported approximately 0.1–4.9 %,13 our data showed that 
approximately 0.66 % of umbilical cord mononuclear cells are CD34+ HSC as we could isolate 1.20×106 CD34+ HSC 
from 170.20 x106 mononuclear cells. Employing double sorting method, we have also demonstrated that the purity of 
separated cells is 81.4% when 50-70 ml of human umbilical cord blood was consumed. 
The purity of HSC to initiate expansion at in vitro culture is considered as a critical factor. In order to promote the 
expansion of HSC by promoting self-renewal but not committing into differentiation, a minimum number and purity 
of HSC is required. Based on various studies reported, the purity of CD34+ HSC around 80-90% is recommended for 
the uninterrupted culture expansion.14  The common practice to reach such a high purity is via flow cytometer mediated 
cell sorting where the purity of sorted cells can achieve up to 90-98%. However, using a simple yet efficient sorting 
method, we have shown that the double sorting technique using magnetic separation could yield such comparatively 
high purity around 81%. In accordance to the initial seeding purity, HSC can be expanded for 7 days with retained 
purity of 90% when analysed by flow cytometer (data not shown). 
Conservation of HSC’s stemness at in vitro culture is an important aspect to be controlled as HSC have a high 
tendency to be committed into progenitors or differentiated into mature cells.15, 16 Although it is difficult to gauge 
such cellular changes through morphological analysis at in vitro culture yet the initial and intermediate processes that 
mediate such silent differentiation could be noticed with gene expression study.2,5 Thus it is always recommended to 
culture HSC in vitro by providing a culture niche that resemble of in vivo physiological condition. Since HSC in bone 
marrow were nurtured in MSC microenvironment that canonically controls the self-renewal and differentiation of 
HSC, hence most of the laboratory based HSC expansion is conducted on stromal cell layer.17,18 However, expanding 
HSC on the surface of feeder cell imposes some technical difficulties especially when harvesting HSC for further 
subculture or to be consumed in experiments. In this present study, two different harvesting methods namely cell 
aspiration and trypsinization were utilized to collect HSC that have been cultured onto MSC feeder layer. In cell 
aspiration method, HSC were harvested by disturbing the adhered HSC by aspirating and dispensing using pipette and 
then washing the cells with PBS.19 Whereas, the trypsinization method involve a mild digestion of membrane proteins 
that formed a tight attachment with feeder cells by using the enzyme trypsin. Our result showed that the number 
of cells harvested using trypsinization method was significantly higher as compared to the cell aspiration method. 
Trypsin is believed to cleave the anchorage of HSC with feeder cells; increases the release of the HSC, hence facilitate 
the collection of HSC from the culture media. Besides that the phase contrast microscopical observation of feeder 
layer at post-harvests of cell aspiration method exhibited a substantial fraction of HSC was adhered on the feeder cells 
(data not shown). This indicates a firmer harvesting method is required in order to fully dissociate the HSC from MSC 
feeder cell layer. Moreover, the technical limitation such as the forceful aspiration and dispense mechanism during the 
cell aspiration harvesting method leads to dislodge of the feeder layer from the cell culture flask.
Although the cell yield from trypsinization harvesting method is significantly higher, yet the quality of HSC 
retrieved was compromised with 74.13% of purity as compared with the initial purity of 81.40%. However, the 
conventional cell aspiration harvesting method maintained the purity at 82.43% after the post expansion on day 5. The 
reduction of purity in trypsinization method could be due to the fact that trypsin causes detachment of feeder cells 
and release of MSC into supernatant. However, the difference was not statistically significant (p>0.05). Although, the 
release of MSC during trypsinization is postulated as a major factor for compromised purity in harvested HSC, yet this 
notion remained to be confirmed. An additional immunophenotyping of cells that been harvested from trypsinization 
method with MSC cell surface will be useful to decipher the contamination of cell harvest by feeder cells.  Moreover, 
the possibility of trypsin digestion to potentially alter the protein conformity of CD34 where it diminishes the optimal 
binding with target antibody could not be negated too. 
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CONCLUSION
The present study showed that the double sorting technique using magnetic separation yields the required CD34+ 
HSC population for in vitro expansion. The expanded HSC on MSC feeder layer can be optimally harvested using cell 
aspiration method to maintain high purity of HSC.   
ACKNOWLEDGMENTS
This work is supported by Putra Grant-Postgraduate initiative (GP-IPS/2014/9432500 from Universiti Putra Malaysia, 
Malaysia.
REFERENCES
1. Andrade PZ, da Silva CL, dos Santos F et al. Initial CD34+ cell-enrichment of cord blood determines 
hematopoietic stem/progenitor cell yield upon Ex vivo expansion. J. Cell Biochem. 2011;112:1822-1831.
2. Robinson S, Niu T, de Lima M et al. Ex vivo expansion of umbilical cord blood. Cytotherapy. 2005;7:243-250.
3. Bonnet D. Hematopoietic stem cells. Birth Defects ResCEmbryoToday. 2003;69:219-229.
4. Boiron JM, Dazey B, Cailliot C et al. Large-scale expansion and transplantation of CD34+ hematopoietic cells: 
in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment 
of the long-term engraftment capacity. Transfusion. 2006;46:1934-1942.
5. Sanchez-Ramos J. Stem cells from umbilical cord blood. Semin Reprod Med. 2006;24:358-369.
6. Gluckman E, Ruggeri A, Volt F et al. Milestones in umbilical cord blood transplantation. Br. J Haematol. 
2011;154:441-447.
7. Resnick I, Stepensky P, Elkin G et al. MSC for the improvement of hematopoietic engraftment. Bone marrow 
transplantation. 2010;45:605-606.
8. Walenda T, Bokermann G, Ferreira MSV et al. Synergistic effects of growth factors and mesenchymal stromal 
cells for expansion of hematopoietic stem and progenitor cells. Experimental hematology. 2011;39:617-628.
9. Bron D, De Bruyn C, Lagneaux L et al. [Hematopoietic stem cells: source, indications and perspectives]. Bull 
Mem Acad R Med Belg. 2002;157:135-145.
10. Dazzi F, Ramasamy R, Glennie S et al. The role of mesenchymal stem cells in haemopoiesis. Blood Rev. 
2005;20 161-171.
11. Jing D, Fonseca A-V, Alakel N et al. Hematopoietic stem cells in co-culture with mesenchymal stromal cells-
modeling the niche compartments in vitro. haematologica. 2010;95:542-550.
12. da Silva CL, Gonçalves R, dos Santos F et al. Dynamic cell–cell interactions between cord blood haematopoietic 
progenitors and the cellular niche are essential for the expansion of CD34+, CD34+ CD38− and early lymphoid 
CD7+ cells. J. Tissue Eng. Regen Med. 2010;4:149-158.
13. Pranke P, Hendrikx J, Debnath G et al. Immunophenotype of hematopoietic stem cells from placental/umbilical 
cord blood after culture. Braz J Med Biol Res. 2005;38:1775-1789.
14. Jing Q, Cai H, Du Z et al. Effects of agitation speed on the ex vivo expansion of cord blood hematopoietic stem/
progenitor cells in stirred suspension culture. Artificial cells, nanomedicine, and biotechnology. 2013;41:98-
102.
15. Bakhshi T, Zabriskie RC, Bodie S et al. Mesenchymal stem cells from the Wharton’s jelly of umbilical cord 
segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term 
ex vivo culture. Transfusion. 2008;48:2638-2644.
The Efficiency of Cell Sorting and Harvesting Methods for In vitro Expansion of Human Umbilical 
Cord Blood derived CD34+ Hematopoietic Stem Cells 
Malaysian Journal of Medicine and Health Sciences Vol. 11 (2) June 2015
28
Malaysian Journal of Medicine and Health Sciences Vol. 11 (2) June 2015
16. Magin AS, Koerfer NR, Partenheimer H et al. Primary Cells As Feeder Cells For Coculture Expansion Of Human 
Hematopoietic Stem Cells From Umbilical Cord Blood A Comparative Study. Stem Cells Dev. 2008;18:173-
186.
17. Muguruma Y, Yahata T, Miyatake H et al. Reconstitution of the functional human hematopoietic microenvironment 
derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood. 2005;107:1878-
1887.
18. Steven MD. Mesenchymal stem cells: Will they have a role in the clinic? J.Cell.Biochem. 2003;38:73-79.
19. Jing D, Fonseca AV, Alakel N et al. Hematopoietic stem cells in co-culture with mesenchymal stromal cells--
modeling the niche compartments in vitro. Haematologica. 2010;95:542-550.
Mohadese Hashem Borojerdi, Maryam Maqbool, Zuraidah Yusoff, Sharmili Vidyadaran, 
Ling King Hwa, Elizabeth George & Rajesh Ramasamy
